Benefit Allocation. Subject to any adjustment in accordance with Section 5.7 or otherwise under this Agreement or the Supply Agreement, the Parties shall share commercial benefits arising from their and their Affiliates' respective activities in connection with the Commercialization of the Products hereunder (the "Benefit Allocation") (i) on an equal basis with respect to the U.S. Territory, and (ii) in accordance with the percentages set forth in the table below with respect to each of the Major EU Countries: Percentage Allocation of Benefit for the Major EU Countries Period During the Applicable Country Term in each of ------------------------------------ the Major EU Countries Idenix Novartis ------------------------------------------------------ --------------- --------------- The 12-month period beginning on the Launch Date in [**]% [**]% such country The 12-month period beginning on the first anniversary [**]% [**]% of the Launch Date in such country Each 12-month period beginning on the second and [**]% [**]% subsequent anniversaries of the Launch Date in such country through the end of the applicable Country Term
Appears in 2 contracts
Sources: Development, License and Commercialization Agreement (Idenix Pharmaceuticals Inc), Development, License and Commercialization Agreement (Idenix Pharmaceuticals Inc)